Health Catalyst, Inc.
Close on Oct 19, 2026
- Market cap
- $126.47M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Next report expected Nov 9, 2026, after market close (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 6, 2026 | After market close | – | – | – |
| Q1 FY2026 Ended Mar 31, 2026 | May 11, 2026 | After market close | – | – | – |
| Q4 FY2025 Ended Dec 31, 2025 | Mar 12, 2026 | After market close | $74.68M | $-1.28 | $0.08 |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 10, 2025 | After market close | $76.32M | $-0.32 | $0.06 |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 7, 2025 | After market close | $80.72M | $-0.59 | $0.04 |
| Q1 FY2025 Ended Mar 31, 2025 | May 7, 2025 | After market close | – | – | – |
| Q4 FY2024 Ended Dec 31, 2024 | Feb 26, 2025 | After market close | – | – | – |
| Q3 FY2024 Ended Sep 30, 2024 | Nov 6, 2024 | After market close | – | – | – |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 7, 2024 | After market close | – | – | – |
| Q1 FY2024 Ended Mar 31, 2024 | May 9, 2024 | After market close | – | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Feb 22, 2024 | After market close | – | – | – |
Company guidance
Outlook given with results on Aug 6, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| Adjusted EBITDAnon-GAAP | full year of 2026 | $18.00M to $18.50M | Lowered |
| Adjusted EBITDAnon-GAAP | third quarter of 2026 | $0 to $500.00K | New |
| Total revenueGAAP | full year of 2026 | $246.00M to $249.00M | Lowered |
| Total revenueGAAP | third quarter of 2026 | $55.00M to $56.00M | New |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Health Catalyst filed with the SEC
Health Catalyst Strengthens Its Board with the Appointment of Tami Reller
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Health Catalyst Appoints Simeon Kohl as Chief Executive Officer and President
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Health Catalyst Reports Second Quarter 2026 Results
Agreement terminated · Acquisition or disposition completed · Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Health Catalyst Completes Sale of Vitalware, Sharpening Its Focus as a Healthcare Intelligence Company
Agreement terminated · Acquisition or disposition completed · Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Unaudited Pro Forma Condensed Consolidated Financial Statements
Agreement terminated · Acquisition or disposition completed · Results of operations · Regulation FD disclosure · EX-99.3 to Form 8-K
Health Catalyst to Divest Vitalware for $147 Million, Accelerating Strategic Transformation
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K
Health Catalyst Reports First Quarter 2026 Results
Results of operations · EX-99.1 to Form 8-K
Health Catalyst Appoints Steve Nelson, President of Aetna, to Its Board of Directors
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Health Catalyst Reports Fourth Quarter and Year End 2025 Results
Results of operations · EX-99.1 to Form 8-K
Health Catalyst Appoints Ben Albert as Chief Executive Officer
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Results of operations · EX-99.1 to Form 8-K
Matt Arens, CEO and Founder of Health Catalyst’s Largest Shareholder, First Light Asset Management, Joins Board of Directors
Material agreement · Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Health Catalyst Reports Third Quarter 2025 Results
Results of operations · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · EX-99.2 to Form 8-K
Health Catalyst Appoints Ben Albert to the Role of President and COO
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Health Catalyst Reports Second Quarter 2025 Results
Results of operations · Executive or director change · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · Executive or director change · EX-99.2 to Form 8-K
Health Catalyst Reports First Quarter 2025 Results
Results of operations · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · EX-99.2 to Form 8-K
Health Catalyst Reports Fourth Quarter and Year End 2024 Results
Results of operations · Executive or director change · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · Executive or director change · EX-99.2 to Form 8-K
Health Catalyst Signs Definitive Agreement to Acquire Upfront Healthcare Services
Material agreement · Unregistered share sale · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
© Health Catalyst. Overview Presentation January 2025
Material agreement · Unregistered share sale · Regulation FD disclosure · Other events · EX-99.2 to Form 8-K
EX-99.3 to Form 8-K
Material agreement · Unregistered share sale · Regulation FD disclosure · Other events · EX-99.3 to Form 8-K
Health Catalyst Reports Third Quarter 2024 Results
Results of operations · Unregistered share sale · Executive or director change · Other events · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · Unregistered share sale · Executive or director change · Other events · EX-99.2 to Form 8-K
Health Catalyst Signs Definitive Agreement to Acquire Top-Rated Cybersecurity Provider, Intraprise Health
Results of operations · Unregistered share sale · Executive or director change · Other events · EX-99.3 to Form 8-K
Health Catalyst Reports Second Quarter 2024 Results
Results of operations · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · EX-99.2 to Form 8-K
Health Catalyst Announces New Credit Facility for up to $225,000,000
Material agreement · New financial obligation · Other events · EX-99.1 to Form 8-K
Health Catalyst Reports First Quarter 2024 Results
Results of operations · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · EX-99.2 to Form 8-K
Health Catalyst Reports Fourth Quarter and Year End 2023 Results
Results of operations · Executive or director change · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · Executive or director change · EX-99.2 to Form 8-K
EX-99.3 to Form 8-K
Results of operations · Executive or director change · EX-99.3 to Form 8-K
© Health Catalyst. Confidential and Proprietary. Overview Presentation January 2024
Other events · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Other events · EX-99.2 to Form 8-K
Health Catalyst Reports Third Quarter 2023 Results
Results of operations · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · EX-99.2 to Form 8-K
Health Catalyst Reports Third Quarter 2023 Preliminary Results
Results of operations · EX-99.1 to Form 8-K